Key result
Plasma ANGPTL3 levels were significantly lower in newly diagnosed type 2 diabetes patients compared to healthy controls (p < 0.05).
Why the study?
ANGPTL3 regulates plasma triglycerides and may affect blood glucose through free fatty acids and insulin resistance, prompting investigation of its correlation with metabolic markers in newly diagnosed type 2 diabetes.
Does plasma ANGPTL3 concentration correlate with lipid and glucose metabolic markers in newly diagnosed type 2 diabetes mellitus patients?
Cross-Sectional (n=201)
Does plasma ANGPTL3 concentration correlate with lipid and glucose metabolic markers in newly diagnosed type 2 diabetes mellitus patients?
Answers are grounded in this paper and cite their sources.
Plasma ANGPTL3 levels are lower in newly diagnosed, untreated type 2 diabetes patients compared to healthy controls, and correlate positively with triglycerides and inversely with HDL-C.
Purpose: Angiopoietin-Like3 is a protein that plays an important role in regulating plasma triglyceride concentrations by inhibiting the enzyme lipoprotein lipase. Lipid metabolism and glucose metabolism are closely related and interact with each other. ANGPTL3 may also be a factor involved in blood glucose regulation through an increase in free fatty acids generated from enhanced lipolysis in adipose tissue leading to insulin resistance. This study aimed to investigate plasma ANGPTL3 concentrations and their correlation with lipid and glucose metabolic markers in newly diagnosed type 2 Diabetes Mellitus patients. Subject and Methods: A cross-sectional descriptive study was conducted on 98 healthy subjects (control group) and 103 patients with type 2 diabetes at the first diagnosis, without any treatment (patient group). Plasma ANGPTL3 concentration was quantified by the ELISA method. The study determines the correlation of ANGPTL3 concentration with some indicators reflecting lipid and glucose metabolism. Results: The concentration of ANGPTL3 in the newly diagnosed type 2 Diabetes Mellitus patient group was lower than in the control group, the difference was statistically significant with p < 0.05. In the patient group: there was an inverse correlation between ANGPTL3 concentration and HDL-C concentration (r = -0.37; p<0.001), and a positive correlation with triglyceride concentration (r = 0.275; p < 0.05). There was no correlation between plasma ANGPTL3 levels and anthropometric indices, total cholesterol, HDL-C, glucose, HbA1C, insulin, and HOMA-IR. In the control group: there was no correlation between ANGPTL3 and any of the indicators mentioned above. Conclusion: ANGPTL3 levels in newly diagnosed type 2 diabetes mellitus patients were statistically significantly lower than in healthy subjects. Plasma ANGPTL3 was positively correlated with triglyceride levels and inversely correlated with HDL-C levels in newly diagnosed type 2 Diabetes mellitus patients.
No takes yet. Share an insight, caveat, or question.
Hoang et al. (2022) conducted a cross-sectional in Type 2 Diabetes Mellitus (n=201). Newly diagnosed type 2 diabetes mellitus vs. Healthy subjects was evaluated on Plasma ANGPTL3 concentration (p=< 0.05). Plasma ANGPTL3 levels were significantly lower in newly diagnosed type 2 diabetes patients compared to healthy controls (p < 0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: